American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression

MedPageToday -- CHICAGO -- Fenretinide could still become the first disease-modifying treatment for geographic atrophy -- the end stage of “dry” age-related macular degeneration (AMD) -- in spite of a bungled phase II trial, researchers said here.